Table 2 Expression and clinical characteristics of SNHG17 in various cancers
From: Long noncoding RNA SNHG17: a novel molecule in human cancers
Cancer Types | Sample Size | Expression | Clinical Characteristics | Survival Analysis | References |
|---|---|---|---|---|---|
Tumor:Normal | Tumor:Normal | ||||
Oral squamous cell carcinoma | 40: 40 | UP | Advanced TNM stages, lymph node metastasis | No description | [40] |
Tongue squamous cell carcinoma | 56: 56 | UP | Advanced tumor size and TNM stages, lymph node metastasis, diagnosis, poorer OS and prognosis | Kaplan–Meier analysis | [41] |
Esophageal squamous cell carcinoma | 126: 126 | UP | Advanced TNM stages, poorer prognosis | No description | [45] |
Lung adenocarcinoma | 50: 50 | UP | Advanced TNM stages, poorer OS and prognosis | Kaplan–Meier analysis | [49] |
Breast cancer | 58: 58 | UP | Advanced TNM stages, lymph node metastasis, poorer prognosis | Kaplan–Meier analysis | [12] |
Gastric cancer | 157: 157 | UP | Advanced TNM stages, lymph node metastasis, distant metastasis, poorer OS and PFS | Kaplan–Meier analysis, multivariate Cox regression | [51] |
Gastric cancer | 112: 112 | UP | Advanced TNM stages and HP infection, lymph node metastasis, poorer prognosis | Kaplan–Meier analysis | [11] |
Gastric cancer | 107: 174 | UP | Advanced TNM stages, invasion depth, lymph node metastasis, diagnosis | ROC curve | [15] |
Colorectal cancer | 56: 56 | UP | Advanced tumor size and TNM stages, lymph node metastasis, poorer prognosis | Kaplan–Meier analysis | [13] |
Rectal cancer | 46: 46 | UP | No description | No description | [54] |
Colon adenocarcinoma | 45: 45 | UP | No description | No description | [53] |
Hepatocellular carcinoma | 23: 23 | UP | Advanced tumor size and Edmonson-Steiner grades | No description | [16] |
Hepatocellular carcinoma | 28: 28 | UP | Shorter OS and PFS, poorer prognosis | Kaplan–Meier analysis | [59] |
Hepatocellular carcinoma | 28: 28 | UP | Advanced tumor size and TNM stages, shorter OS and DFS, poorer prognosis | Kaplan–Meier analysis, univariate and multivariate Cox regression | [60] |
Pancreatic cancer | 30: 30 | UP | No description | No description | [62] |
Prostate cancer | 58: 58 | UP | Advanced TNM stages, poorer prognosis | Kaplan–Meier analysis | [66] |
Prostate cancer | 36: 36 | UP | Poorer prognosis and PFS | Kaplan–Meier analysis | [67] |
Renal cell carcinoma | 84: 84 | UP | Advanced TNM stages, shorter OS, higher recurrence rate | Kaplan–Meier analysis, univariate and multivariate Cox regression | [64] |
Ovarian Cancer | 90: 90 | UP | Larger tumor size, advanced FIGO stage and histological grade, poorer prognosis | Kaplan–Meier analysis | [70] |
Cervical cancer | 124: 119 | UP | Diagnosis, advanced tumor size and FIGO stage, lymph node metastasis | No description | [86] |
Melanoma | 148: 148 | UP | Lymph node metastasis, advanced tumor stage, poorer prognosis and OS | Kaplan–Meier analysis, multivariate Cox regression | [77] |
Osteosarcoma | 5: 5 | UP | Poorer prognosis and OS | Kaplan–Meier analysis | [18] |